TickerFacts.

Medline Inc. (MDLN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$1.30B
Year ended 2025-12-31
$1.55B
Trailing 12 months to 2026-06-27
$1.42B2023-12-31: $1.41B2024-12-31: $1.42B2025-12-31: $1.30B$1.30B
2023-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$1.30B-8.3%2026-02-25, From 2025-01-01
2024-12-31$1.42B+0.4%2026-02-25, From 2024-01-01
2023-12-31$1.41Bn/a2026-02-25, From 2023-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Medline Inc. (MDLN)2025-12-31$1.30B-8.3%
Stryker Corp (SYK)2025-12-31$4.28B+22.8%
3M Co (MMM)2025-12-31$1.40B+118.8%
Becton Dickinson & Co (BDX)2025-09-30$2.67B-14.4%
Boston Scientific Corp (BSX)2025-12-31$3.66B+38.3%
Baxter International Inc (BAX)2025-12-31$332.00M-42.1%
Solventum Corp (SOLV)2025-12-31-$10.00Mn/m
ResMed Inc (RMD)2026-06-30$1.65B-0.7%
Dexcom Inc (DXCM)2025-12-31$1.08B+70.8%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗